AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Permian Basin Royalty Trust, you really have to believe in its role as a pure royalty vehicle whose value lives and dies with commodity prices, production volumes and operator decisions rather than any growth plan of its own. The latest cut to the monthly distribution to US$0.020355 per unit follows a sharp step-down from April’s higher payout, reinforcing how quickly cash flow can reset even after a stronger first quarter, higher revenue and very large historical total returns. In the near term, the key catalyst remains how consistently operators can generate payable royalties after excess cost periods, while the biggest risk is that income proves too erratic to justify the current high price to earnings multiple. This new, lower distribution sits squarely in that risk conversation.
However, one income risk here may surprise investors who only look at the yield. Permian Basin Royalty Trust's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.Explore another fair value estimate on Permian Basin Royalty Trust - why the stock might be worth as much as $9.37!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com